Psagot Investment House Ltd. grew its position in shares of Aetna Inc. (NYSE:AET) by 5.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,981 shares of the company’s stock after buying an additional 1,946 shares during the quarter. Psagot Investment House Ltd.’s holdings in Aetna were worth $6,198,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently bought and sold shares of AET. FMR LLC grew its holdings in shares of Aetna by 73.8% during the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after buying an additional 5,833,567 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in Aetna by 9,446.2% in the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after purchasing an additional 4,283,553 shares during the last quarter. Capital World Investors boosted its holdings in Aetna by 8.9% in the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after purchasing an additional 1,688,767 shares during the last quarter. Samlyn Capital LLC purchased a new stake in Aetna in the second quarter worth approximately $77,170,000. Finally, Parametric Portfolio Associates LLC boosted its holdings in Aetna by 63.7% in the second quarter. Parametric Portfolio Associates LLC now owns 1,113,972 shares of the company’s stock worth $169,134,000 after purchasing an additional 433,372 shares during the last quarter. Hedge funds and other institutional investors own 88.03% of the company’s stock.
In related news, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping analysts’ consensus estimates of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. During the same period last year, the company posted $2.07 EPS. The business’s revenue was down 5.0% on a year-over-year basis. equities analysts predict that Aetna Inc. will post 9.78 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. Aetna’s payout ratio is currently 37.04%.
Several equities research analysts recently issued reports on the stock. Wells Fargo & Company restated an “outperform” rating and issued a $208.00 target price (up previously from $200.00) on shares of Aetna in a report on Monday. BMO Capital Markets increased their price target on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research report on Friday, October 27th. Cantor Fitzgerald downgraded shares of Aetna from an “overweight” rating to a “neutral” rating in a research report on Thursday, October 26th. Raymond James Financial upgraded shares of Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price target on the stock in a research report on Friday, November 3rd. Finally, Piper Jaffray Companies reiterated a “hold” rating and issued a $187.00 price target on shares of Aetna in a research report on Friday, November 3rd. Eleven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Aetna currently has a consensus rating of “Buy” and an average target price of $174.14.
TRADEMARK VIOLATION WARNING: This news story was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.chaffeybreeze.com/2017/12/06/aetna-inc-aet-stake-raised-by-psagot-investment-house-ltd.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.